Impact Factor
7.883
Call For Paper
Volume 10 Issue 12 December 2024
LICENSE
DRUG PROFILE OF IVACAFTOR AND LUMACAFTOR
-
Author(s):
N.MD.Akram (Research Scholar) | Dr. M. Umamahesh
-
Keywords:
Ivacaftor And Lumacaftor, Cystic Fibrosis Transmembrane Conductance Regulator.
-
Abstract:
Ivacaftor And Lumacaftor Are Vocally Available In The Form Of Correctors Of The Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) That Are Used To Care For Patients With Cystic Fibrosis With Specific Mutations Of The CFTR. Ivacaftor Alone Or In
Other Details
-
Paper id:
IJSARTV4I321446
-
Published in:
Volume: 4 Issue: 3 March 2018
-
Publication Date:
2018-03-14
Download Article